Tom Brokaw to Deliver Keynote at 2015 BIO International Convention

Posted by Steve Joseph on Apr 23, 2015 12:17:00 PM

June 15-18, 2015 | Philadelphia

Recently we published a blog post called 10 Reasons to Attend BIO International Convention, but here's another great one: Veteran journalist and author Tom Brokaw will deliver a keynote address at a Tuesday luncheon (12-1:30) at the Pennsylvania Convention Center.

The BIO International Convention draws more than 15,000 leaders from the biopharmaceutical industry each year and provides a myriad of opportunities for networking, partnering and seeking licensing deals.

Tom Brokaw, a journalistic icon whose trusted insights have changed the way we think about the world, has traveled the globe to cover elections, summits, political turmoil, war, and major news stories of every description. Even after stepping aside from two decades at the helm of NBC Nightly News, Tom Brokaw is now more engaged than ever in finding stories that show the strength, perseverance and 

courage of people not only here at home, but around the globe. From the turmoil of the Vietnam War and the fall of the Berlin Wall to the war zones of Iraq and Afghanistan and the hallowed ground of Normandy, where he interviewed President Obama during the anniversary commemoration of D-Day, Brokaw has the journalistic acumen and global experience to help us make sense of the complex stories of our times.

Register for the conference before April 23 for early bird discounts.

Read More

Topics: Information, Life Sciences, Events

8 Reasons to Attend the 2nd Due Diligence Summit for Life Sciences

Posted by Steve Joseph on Apr 22, 2015 12:08:00 PM

JUNE 9-10 | BOSTON | ExL Events

Competition is fierce in today’s Life Sciences industry, making it more important than ever to perform due diligence that is both thorough and effective.

As the only Life Science educational event dedicated to due diligence, the 2nd Due Diligence Summit For Life Sciences, presented by ExL Events, focuses on running a tight ship throughout the due diligence process. During the summit, experts from a variety of pharmaceutical companies will discuss why success in today’s market can depend heavily on having a well-defined business development plan, which includes acquisitions and in-licensing strategies and well as understanding which products, drugs and companies they should focus on acquiring.

Comprehensive due diligence is a key component in measuring the profitability and efficacy of a potential product. It also helps to mitigate the risks that come from taking on a new product, portfolio or company, as well as facilitate the negotiation of a mutually beneficial contract and ensure regulatory compliance.

Read More

Topics: Life Sciences, Events, Partnerships

Prepare for Success at the BIO International Convention by Attending These Classes

Posted by Steve Joseph on Apr 20, 2015 8:09:00 AM

If you’re planning to attend the BIO International Convention in Philadelphia (June 15th – 18th) this year you might consider arriving a couple days early to take advantage of one of two courses that BIO is offering to help attendees maximize the value and success of the time they spend at the convention.

The courses are held in the same location as the BIO International Convention, but take place on Saturday and Sunday and continue on Monday when the convention begins.

The two coinciding courses are designed to prepare and support the attendees of the conference who are focused on making deals, seeking investors or partners, or raising venture capital during the convention. The courses are taught by experienced business development professionals from leading pharmaceutical and biotechnology firms, and experts from the fields of law and public relations. All of the instructors have deep hands-on experience with doing deals and negotiating licensing agreements in the biotech industry.

Read More

Topics: Life Sciences, Events, Partnerships

What’s Hot & What’s Not in Gene Therapies for Rare Disorders [Web Panel Discussion]

Posted by Steve Joseph on Apr 16, 2015 7:31:50 AM

MAY 6th, 2015


Exciting new gene and cell therapy technologies have the potential to treat devastating inherited diseases and rare disorders for which there is little hope of finding a conventional cure. Recently this sector of the life sciences industry has been among the hottest biotechnology arenas for IPOs and licensing deals.

On May 6th, at 11am PDT / 2pm EDT, ShareVault, in partnership with Defined Health and the Biotechnology Industry Organization (BIO), will present a web panel discussion on the cutting-edge advances in genetic therapies that are likely to provide game-changing treatments, if not cures, for patients with rare inherited disorders.

Discussion topics covered during the web panel will include advanced viral vector platforms that are likely to reach the market in the next couple of years, as well as what’s on the horizon following exciting recent breakthroughs in gene editing.

The panelists will also discuss the opportunities, as well as the issues, facing those seeking to commercialize new therapeutic approaches. These issues will be debated from the perspective of gene therapy pioneers, biopharma executives developing business models to deliver therapies to patients, and payer perspectives on how such potentially curative one-time treatments are likely to be reimbursed in the US and other payer systems.

Read More

Topics: Information, Webinars, Life Sciences, Events, Partnerships

7 M&A Deal Killers and How to Avoid Them [Info Graphic]

Posted by John Badger on Apr 7, 2015 8:16:49 AM

Based on the white paper by David Stastny, Centaur Partners LLC

Given today’s very active technology merger and acquisition market, and given that it looks to remain strong, it makes sense to examine the state of your company in order to maximize the value of your exit. Technology companies are generally bought, not sold, and the largest buyers—companies like IBM, Google, Oracle, and Citrix, to name a few—are looking at smaller companies on an ongoing basis to expand their portfolios. Constant readiness then becomes imperative in order to both look attractive to potential buyers and to maximize the value of your company.

Download the  White Paper

Too often, however, technology companies seeking a profitable exit make the flawed assumption that the due diligence and valuation process resides solely in the hands of the buyer. This assumption can lead to fatal mistakes that can undermine value, slow the process, or even kill the deal. The truth is, as a selling company, you have an enormous opportunity to shorten due diligence timelines and maximize the value that the buyer assigns to your company. 

Today’s buyer can be ruthless in evaluating your company’s strengths and weaknesses. Many due diligence teams will attempt to steamroll you in order to expose risks and reduce value. How do you ensure that you’ve done all you can to look good in the face of this kind of scrutiny? Putting yourself in the buyer’s shoes and anticipating what they will be looking for is the best way to ensure that your company will be ready when a buyer knocks on the door.

Read More

Topics: Information, M&A

Best Practices for Technology Transfer

Posted by Steve Joseph on Mar 26, 2015 9:45:27 AM

Universities, hospitals and research institutes conduct research that generates groundbreaking inventions that not only save lives, but also improve the way people live, work and play on a daily basis. Technology transfer is the process of getting these ideas out of the lab and classroom and into the market. Technology transfer offices facilitate the transfer of these discoveries to companies that can in turn develop them into products and services that benefit society.

During this process, technology transfer offices at universities and research institutes are challenged with providing all of the documentation and information needed for potential licensees to evaluate a technology, without losing control of the underlying intellectual property or violating open records regulations. More and more technology transfer offices across the globe are finding that a secure virtual data room is the ideal platform for managing and protecting the technology transfer process.

Read More

Topics: Tech Transfer

The 7 Habits of Highly Effective Data Rooms

Posted by John Badger on Mar 17, 2015 12:26:00 PM

A virtual data room is the ideal platform for the simple, secure and organized sharing of confidential documents with third parties during due diligence for M&A, partnering, fundraising, and asset sales. But not all data rooms are created equal.

When shopping for a virtual data room, look for one that provides the highest level of features and functionality, but also one that is intuitive to use and quick to deploy.

A good virtual data room should require very limited training and should be able to be populated with comprehensive due diligence materials in the matter of an hour or two, not days. When evaluating virtual data rooms for your application, look for the following characteristics and features:


    At the heart of any modern virtual data room is the ability to secure and control sensitive documents while sharing them with third parties. A good virtual data room utilizes enterprise-grade security, even on computers and devices that are outside the control of a firm’s IT department. This security technology should be applied uniformly, regardless of whether documents are viewed on Windows, Macs, or iOS devices.

Read More

Topics: Information, White Papers, Products

10 Reasons to Attend BIO International Convention

Posted by Steve Joseph on Mar 13, 2015 8:34:00 AM

June 15th – 18th, 2015 | Philadelphia

The BIO International Convention is hosted by the Biotechnology Industry Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

BIO performs many services for members, but none of them are more visible than the BIO International Convention, an event that helps BIO fulfill its mission to help grow the global biotech industry. Profits from the BIO International Convention are returned to the biotechnology industry by supporting BIO programs and initiatives. BIO also works throughout the year to create a policy environment that enables the industry to pursue its vision of bettering the world through biotechnology innovation.

Read More

Topics: Events

How BIO and ShareVault Can Help Life Science Companies Save Big Money [video]

Posted by Steve Joseph on Mar 5, 2015 8:10:00 AM

Here at ShareVault we know that growing a life science company isn't easy. Sometimes it feels like a lonely battle when you’re trying to secure the goods and services your company needs to survive. Why go it alone? The Biotechnology Industry Organization (BIO) has created the industry’s largest cost-saving program: BIO Business Solutions®.

Read More

Topics: Life Sciences, Partnerships

How is Your Company Addressing Rogue IT?

Posted by John Badger on Mar 3, 2015 11:44:00 AM

According to TechTarget, "Rogue IT" is the use of unsanctioned information technology resources within an organization.  Is your company heading down the slippery slope of rogue IT?  Are your employees downloading unauthorized apps on personal devices or using Dropbox, Google Docs, or other SaaS platforms that can lead to document leakages, lost business and financial penalties? When employees begin relying on their personal smartphones and cloud apps to get “anywhere, anytime” access to company systems and data, they no longer see the need for the IT middleman. It’s known as “Shadow IT” and it’s definitely a problem in today’s enterprise. Enterprise IT vendor recently ran a competition to highlight the problem. They asked participants to provide the best (or worst, depending on your perspective) example of rogue IT gone wrong. Here are the winners:

Read More

Topics: Information

About ShareVault

Simple & Secure Document Sharing

ShareVault offers virtual data rooms for securely sharing documents with third parties. Typically used to share due diligence documents during M&A, partnering, fundraising and other dealmaking scenarios, ShareVault is increasingly being used for a wide variety of other applications, primarily in highly regulated industries, for securely sharing documents with third parties. ShareVault can be set up and deployed in an hour, yet offers enterprise-grade security and scaleability.

Learn More about sharing documents simply and securely with ShareVault

Subscribe to Email Updates